| 書(shū)目名稱(chēng) | Nanomedicine for Cancer Therapy |
| 副標(biāo)題 | From Chemotherapeuti |
| 編輯 | Piyush Kumar,Rohit Srivastava |
| 視頻video | http://file.papertrans.cn/661/660839/660839.mp4 |
| 概述 | Reports on clinical trials success and challenges.Details the mechanism of drug resistance.Includes supplementary material: |
| 叢書(shū)名稱(chēng) | SpringerBriefs in Applied Sciences and Technology |
| 圖書(shū)封面 |  |
| 描述 | .This Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach.?. |
| 出版日期 | Book 2017 |
| 關(guān)鍵詞 | Drug delivery for cancer; Cancer theranostic agent; Therapeutic diagnosis; Breast cancer; Multiple drug |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-45826-7 |
| isbn_softcover | 978-3-319-45825-0 |
| isbn_ebook | 978-3-319-45826-7Series ISSN 2191-530X Series E-ISSN 2191-5318 |
| issn_series | 2191-530X |
| copyright | The Author(s) 2017 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-6 03:58
發(fā)表于 2025-3-21 19:49:49
